Condition
Atrial Cardiomyopathy
Total Trials
6
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Not Yet Recruiting2
Unknown1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07697469Not Yet Recruiting
Atrial Cardiomyopathy in Patients With Cardiovascular-Kidney-Metabolic Syndrome: Non-invasive Characterization
NCT07648329Not Yet Recruiting
Association Between Circulating BDNF Levels and Atrial Cardiomyopathy in Patients Undergoing Ablation for Persistent Atrial Fibrillation
NCT07009639RecruitingPrimary
Prognostic Role of AI-Echo
NCT05521451Recruiting
Clinical Cohort Study - TRUST
NCT06200311Not ApplicableRecruiting
Atrial Fibrillation (AF) Ablation to Prevent Disease Progression of AF-induced Atrial Cardiomyopathy in Women and Men
NCT05565183Not ApplicableUnknown
Combined Study of ATrial Strain and Voltage by High Density Mapping in Young Patients With Atrial Fibrillation.
Showing all 6 trials